Complete metastasectomy after high-dose interleukin-2 (HD IL-2) therapy for melanoma

Por Chu, Melinda, Hsueh, Eddy, Richart, John
Publicado no J Immunother Cancer (2015)

Efficacy of topical brimonidine-timolol for haemangioma of infancy and perils of off-label prescribing

Por Chu, Melinda B, Searcy, Garrett, Siegfried, Elaine
Publicado em 2013

Coexistent dermatofibrosarcoma protuberans and anticonvulsant-induced cutaneous lymphoid hyperplasia: diagnostic challenge

Por Chu, Melinda B, Dhandha, Maulik, Guo, Aibing
Publicado em 2013

Coexistent metastatic melanoma of the kidney with unknown primary and renal cell carcinoma

Por Dhandha, Maulik, Chu, Melinda B, Richart, John M
Publicado no BMJ Case Rep (2012)

High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients with Melanoma Brain Metastases

Por Chu, Melinda B., Fesler, Mark J., Armbrecht, Eric S., Fosko, Scott W., Hsueh, Eddy, Richart, John M.
Publicado em 2013

Iceberg hemangioma: A segmental cutaneous lesion marking extensive extracutanous involvement

Por Patel, Ashaki, Chu, Melinda B., Wild, Alan, Reis, Martin, Frieden, Ilona J., Drolet, Beth, Siegfried, Elaine C.
Publicado no JAAD Case Rep (2018)

Evaluation of the Definitions of “High-Risk” Cutaneous Squamous Cell Carcinoma Using the American Joint Committee on Cancer Staging Criteria and National Comprehensive Cancer Netwo...

Por Chu, Melinda B., Slutsky, Jordan B., Dhandha, Maulik M., Beal, Brandon T., Armbrecht, Eric S., Walker, Ronald J., Varvares, Mark A., Fosko, Scott W.
Publicado em 2014